Lack of effect of food on the steady state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects

Biopharmaceutics and Drug Disposition

Volumn 18, Issue 7, 1997, Pages 585-593

  Srinivas, Nuggehally R ^a   Shyu, Wen Chyi ^a   Lee, James ^a   Greene, Douglas S ^a   Barbhaiya, Rashmi H ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Anti depressants; BMS 181101; Food

Indexed keywords

5 FLUORO 3 [3 [4 (5 METHOXY 4 PYRIMIDINYL) 1 PIPERAZINYL]PROPYL] 1H INDOLE; ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; ASTHENIA; BIOAVAILABILITY; CLINICAL TRIAL; CONFUSION; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; FOOD DRUG INTERACTION; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; NAUSEA; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; AREA UNDER CURVE; CROSS-OVER STUDIES; DIET; FASTING; FOOD-DRUG INTERACTIONS; HUMANS; MALE; PIPERAZINES; PYRIMIDINES;

EID: 0030798290     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199710)18:7<585::AID-BDD43>3.0.CO;2-L     Document Type: Article

References (22)

1. 14C-BMS-181101 in rats and monkeys. Pharm. Res., 10 (suppl.), S376 (1994).
2. B. Schimd, M. D. Bircher, R. Presnig and A. Kupfer, Polymorphic dextromelhorphan metabolism: co-segregation of oxidative o-demethylation with debrisoquin hydroxylation. Clin. Pharmacol. Ther., 38, 618-624 (1985).
3. M. Gibaldi and D. Perrier, Pharmacokineticx, 2nd edn, Dekker, New York, 1982, pp. 409-417.
4. S. Reigelman and P. Collier, The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J. Pharmacokinet. Biopharm., 8, 509-534 (1980).
5. R. H. Farmen, J. F. Muniak and K. A. Pittman, Management of pharmacokinetic data using HP-3357/mainframe IBM interfacing. Drug Inf. J., 21, 141-153 (1987).
6. B. J. Winer, Statistical Principles in Experimental Design. 2nd edn, McGraw-Hill, New York, 1971, pp. 518-520.
7. G. E. P. Box and D. R. Cox. Analysis of transformations, J. R. Stat. Soc. B, 26, 211-252 (1964).
8. M. Hollander and D. A. Wolfe. Nonpurametric Statistical Methods. Wiley, New York, 1973, 1973, pp. 27-28.
9. P. G. Welling. Influence of food and diet on gastrointestinal drug absorption: a review. J. Pharmarokinet. Biopharm., 5, 291-334 (1977).
10. R. H. Barbhaiya, W. A. Craig, H. P. Corrick-Wcst and P. G. Welling, Pharmacokinetics of hydrochlorothiazide in fasted and fed subjects: a comparison of plasma and urinary excretion methods. J. Pharm. Sci., 71, 245-248 (1982).
11. P. G. Welling and R. H. Barbhaiya. Influence of food and fluid volume on chlorthiazide bioavailabihty: comparison of plasma and urine excretion methods. J. Pharm. Sci., 71, 322-335 (1982).
12. E. S. Vessel, Complex effects of diet on drug disposition. Clin. Pharmacol. Ther., 36, 285-296 (1984).
13. P. J. Neuvonen. Interactions with the absorption of tetracyclincs. Drugs, 11, 45-54 (1976).
14. P. G. Welling, P. A. Koch, C. C. Lau and W. A. Craig, Bioavailabihty of tetracycline and doxycycline in fasted and nonfasted subjects. Antimicrob. Agents Chemother., 11, 462-469 (1977).
15. W. C. Shyu, C. A. Knupp, K. A. Pitmann, L. Dunkle and R. H. Barbhaiya. Food-induced reduction in bioavailabihty of didanosinc. Clin. Pharmacol. Ther., 50, 503-507 (1991).
16. A. Melander, K. Danielson, B. Schersten and E. Wahlin, Enhancement of the bioavailabihty of propranol and metoprolol by food. Clin. Pharmacol. Ther., 22, 108-112 (1977).
17. H. Liedholm, E. Wahin-Boll and A. Melander. Mechanisms and variations in the food effect on propranolol bioavailability. Eur. J. Clin. Pharmacol., 8, 469-475 (1990).
18. R. H. Levy, W. H. Pitlick, A. S. Troupin, J. R. Green and J. M. Neal, Pharmacokinetics of carbamazepine in normal man. Clin. Pharmacol. Ther., 17, 657-668 (1975).
19. C. B. Nemeroff, Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression. J. Clin. Psychopharmacol., 13 (suppl. 2), 10S-17S (1993).
20. S. H. Ingwersen, T. G. Mant and J. J. Larsen, Food intake increases the relative oral bioavailabihty of vanoxerine. Br. J. Clin. Pharmacol., 35, 308-310 (1993).
21. J. Van Marten, P. Van Bemniel, M. R. Dobrinska, R. K. Ferguson and M. Raghoebar. Bioavailability of fluvoxamine given with and without food. Biopharm. Drug Disposit., 12, 571-576 (1991).
22. R. Dockens, D. Greene and R. Barbhaiya. The Lack of effect of food on the bioavailabihty of nefazadone tablets. Biopharm. Drug Disposit., 17, 135-143 (1996).